References
*Based on a claims-based analysis of 8985 patients with newly diagnosed and chronic schizophrenia. Individuals had ≥2 claims with a diagnosis code for schizophrenia on separate dates during 2011. The mean cost per patient was compared to the costs in a demographically adjusted nonschizophrenic population.
  1. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76.
  2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2022.
  3. World Health Organization. Schizophrenia. Accessed May 26, 2022. https://www.who.int/news-room/fact-sheets/detail/schizophrenia
  4. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Ann Rev Clin Psychol. 2014;10:425-438.
  5. Fitch K, et al. Resource utilization and cost in a commercially insured population with schizophrenia. Am Health Drug Benefits. 2014;7(1):18-26.